CA1107646A - Anti-microbial composition - Google Patents

Anti-microbial composition

Info

Publication number
CA1107646A
CA1107646A CA299,788A CA299788A CA1107646A CA 1107646 A CA1107646 A CA 1107646A CA 299788 A CA299788 A CA 299788A CA 1107646 A CA1107646 A CA 1107646A
Authority
CA
Canada
Prior art keywords
glucanase
physarum
beta
extract
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA299,788A
Other languages
English (en)
French (fr)
Inventor
David A.L. Davies
Anthony M.S. Pope
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of CA1107646A publication Critical patent/CA1107646A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01108—Lactase (3.2.1.108)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01021—Beta-glucosidase (3.2.1.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01025—Beta-mannosidase (3.2.1.25), i.e. mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01039—Glucan endo-1,3-beta-D-glucosidase (3.2.1.39)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01052—Beta-N-acetylhexosaminidase (3.2.1.52)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01058—Glucan 1,3-beta-glucosidase (3.2.1.58)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01073—Licheninase (3.2.1.73)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01075—Glucan endo-1,6-beta-glucosidase (3.2.1.75)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01084—Glucan 1,3-alpha-glucosidase (3.2.1.84), i.e. mutanase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA299,788A 1977-03-28 1978-03-28 Anti-microbial composition Expired CA1107646A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB12919/77 1977-03-28
GB12919/77A GB1576891A (en) 1977-03-28 1977-03-28 Antimicrobial compositions containing extracts of light enzymes from physarum species

Publications (1)

Publication Number Publication Date
CA1107646A true CA1107646A (en) 1981-08-25

Family

ID=10013545

Family Applications (1)

Application Number Title Priority Date Filing Date
CA299,788A Expired CA1107646A (en) 1977-03-28 1978-03-28 Anti-microbial composition

Country Status (20)

Country Link
JP (1) JPS542310A (de)
AT (1) AT363589B (de)
AU (1) AU519066B2 (de)
BE (1) BE865369A (de)
CA (1) CA1107646A (de)
DE (1) DE2813282A1 (de)
DK (1) DK134678A (de)
ES (1) ES468236A1 (de)
FI (1) FI780933A7 (de)
FR (1) FR2385730A1 (de)
GB (1) GB1576891A (de)
GR (1) GR71706B (de)
IE (1) IE46698B1 (de)
IL (1) IL54364A0 (de)
NL (1) NL7803291A (de)
NO (1) NO781035L (de)
NZ (1) NZ186783A (de)
PT (1) PT67826B (de)
SE (1) SE7803456L (de)
ZA (1) ZA781758B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2569107A1 (fr) * 1984-08-17 1986-02-21 Squibb & Sons Inc Suppositoires antifongiques adhesifs a longue duree

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58134014A (ja) * 1982-02-03 1983-08-10 Rooto Seiyaku Kk 義歯洗浄用組成物
JPH0261164A (ja) * 1988-08-27 1990-03-01 Hisaka Works Ltd 処理槽への内槽装填・取り出し方法およびそれに用いる移載車。
JPH0261163A (ja) * 1988-08-27 1990-03-01 Hisaka Works Ltd 繊維材料取り出し方法およびそれに用いる装置
DE69710328T2 (de) * 1996-06-07 2002-10-24 Dsm N.V., Heerlen Verwendung einer fungiziden zusammensetzung als pflanzenschutzmittel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2569107A1 (fr) * 1984-08-17 1986-02-21 Squibb & Sons Inc Suppositoires antifongiques adhesifs a longue duree

Also Published As

Publication number Publication date
DK134678A (da) 1978-09-29
NZ186783A (en) 1980-12-19
IL54364A0 (en) 1978-06-15
FR2385730A1 (fr) 1978-10-27
AT363589B (de) 1981-08-10
FI780933A7 (fi) 1978-09-29
GR71706B (de) 1983-06-21
AU3447978A (en) 1979-09-27
ZA781758B (en) 1979-05-30
BE865369A (fr) 1978-09-28
ES468236A1 (es) 1978-12-01
NL7803291A (nl) 1978-10-02
PT67826B (en) 1979-09-27
PT67826A (en) 1978-04-01
ATA215978A (de) 1981-01-15
NO781035L (no) 1978-09-29
FR2385730B1 (de) 1981-07-10
AU519066B2 (en) 1981-11-05
JPS542310A (en) 1979-01-09
GB1576891A (en) 1980-10-15
DE2813282A1 (de) 1978-10-12
IE46698B1 (en) 1983-08-24
SE7803456L (sv) 1978-09-29
IE780623L (en) 1978-09-28

Similar Documents

Publication Publication Date Title
US4062941A (en) Method for treating fungal infections using cell lytic enzymes
Dubos et al. Studies on a bactericidal agent extracted from a soil bacillus: III. Preparation and activity of a protein-free fraction
Pappagianis et al. Development of resistance to amphotericin B in Candida lusitaniae infecting a human
KR101736790B1 (ko) 바실러스, 히알루론산 효소, 및 그의 용도
Trahan et al. Transport and phosphorylation of xylitol by a fructose phosphotransferase system in Streptococcus mutans
Shlaes et al. Infection caused by vancomycin-resistant Streptococcus sanguis II
EP0201332B1 (de) Gegen Infektionen aktive Verbindung
US4144327A (en) Antimicrobial composition comprising lytic enzymes from physarum and an antimycotic agent
Goldstein et al. Studies on the pathogenesis of experimental Candida parapsilosis and Candida guilliermondii infections in mice
EP0964685B1 (de) Verfahren und zusammensetzung zur behandlung von mykosen in tieren
Cinco et al. A microbiological survey on the activity of a hydroalcoholic extract of camomile
Kligman et al. In vitro and in vivo activity of candicidin on pathogenic fungi
GB1576891A (en) Antimicrobial compositions containing extracts of light enzymes from physarum species
EP0445280B1 (de) Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren
Kim et al. Polyene-resistant mutants of Aspergillus fennelliae: sterol content and genetics
Gilbert et al. Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis
Callow et al. Licheniformin, an antibiotic substance from Bacillus licheniformis, active against Mycobacterium tuberculosis
RU2233171C2 (ru) ПОЛИФУНКЦИОНАЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ L-ЛИЗИН-α-ОКСИДАЗЫ ИЗ ГРИБА РОДА TRICHODERMA И СПОСОБ ПОЛУЧЕНИЯ ЭТОГО ФЕРМЕНТА
Louie et al. Relationship between Candida albicans epidermolytic proteinase activity and virulence in mice
KANAOKA et al. Antitumor activity of streptococcal acid glycoprotein produced by Streptococcus pyogenes Su
US3786141A (en) Method of production of anti-tumor substances
Eastridge JR et al. L-form infection of the rat kidney: effect of water diuresis
Emmart et al. The tuberculostatic action of Nocardia extracts in white mice
de Lomas et al. Chemotherapy of Aspergillus fumigatus keratitis: an experimental study
EP0661293A2 (de) Protein mit Zellwachstumsstimulierender und Makrophage chemotaktischer Wirkung, Verfahren zur Herstellung und Verwendung

Legal Events

Date Code Title Description
MKEX Expiry
MKEX Expiry

Effective date: 19980825